JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M701920200 on May 29, 2007

J. Biol. Chem., Vol. 282, Issue 29, 21301-21307, July 20, 2007
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/29/21301    most recent
M701920200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanaka, A.
Right arrow Articles by Shimizu, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanaka, A.
Right arrow Articles by Shimizu, T.

Critical Role of the Heme Axial Ligand, Met95, in Locking Catalysis of the Phosphodiesterase from Escherichia coli (Ec DOS) toward Cyclic diGMP*Formula

Atsunari Tanaka, Hiroto Takahashi, and Toru Shimizu1

From the Institute of Multidisciplinary Research for Advanced Materials, Tohoku University, Katahira, Sendai 980-8577, Japan

Received for publication, March 5, 2007 , and in revised form, May 9, 2007.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Heme-regulated phosphodiesterase from Escherichia coli (Ec DOS) is a gas-sensor enzyme that hydrolyzes cyclic dinucleotide-GMP, and it is activated by O2 or CO binding to the Fe(II) heme. In contrast to other well known heme-regulated gas-sensor enzymes or proteins, Ec DOS is not specific for a single gas ligand. Because Arg97 in the heme distal side in Ec DOS interacts with the O2 molecule and Met95 serves as the axial ligand on the distal side of the Fe(II) heme-bound PAS domain of Ec DOS, we explored the effect of mutating these residues on the activity and gas specificity of Ec DOS. We found that R97A, R97I, and R97E mutations do not significantly affect regulation of the phosphodiesterase activities of the Fe(II)-CO and Fe(II)-NO complexes. The phosphodiesterase activities of the Fe(II)-O2 complexes of the mutants could not be detected due to rapid autoxidation and/or low affinity for O2. In contrast, the activities even of the gas-free M95A and M95L mutants were similar to that of the gas-activated wild-type enzyme. Interestingly, the activity of the M95H mutant was partially activated by O2, CO, and NO. Spectroscopic analysis indicated that the Fe(II) heme is in the 5-coordinated high-spin state in the M95A and M95L mutants but that in the M95H mutant, like wild-type Ec DOS, it is in the 6-coordinated low-spin state. These results suggest that Met95 coordination to the Fe(II) heme is critical for locking the system and that global structural changes around Met95 caused by the binding of the external ligands or mutations at Met95 releases the catalytic lock and activates catalysis.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Cyclic dinucleotide-GMP (c-diGMP)2 is a novel intracellular second messenger that regulates cell motility, differentiation, development, virulence, antibiotic formation, and biofilm formation in bacteria growth and factor-stimulated proliferation in human colon cancer cells (110). Enzymes involved in the biosynthesis and breakdown of c-diGMP contain highly homologous GGDEF or EAL subdomains, respectively (110). The GGDEF subdomain expresses diguanylate cyclase activity, and catalyzes the synthesis of one molecule of cyclic diGMP from two molecules of GTP via the linear intermediate diguanosine tetraphosphate. The GGDEF subdomain is ~180 amino acids long and has a conserved amino acid sequence, GG(D/E)(D/E)F. The EAL subdomain has a phosphodiesterase activity that hydrolytically cleaves cyclic diGMP into l-diGMP and/or GMP, and is 260 residues in length, including the conserved amino acid sequence EAL. Metabolism of c-diGMP may be physiologically important because the genome of Escherichia coli K-12, for example, encodes 19 proteins with GGDEF subdomains and 17 with EAL subdomains.

Heme-regulated phosphodiesterase from E. coli (Ec DOS) contains a heme-bound PAS domain in the N-terminal region and a phosphodiesterase domain with GGDEF and EAL subdomains in the C-terminal region (11, 12). Although Ec DOS also contains a GGDEF subdomain, it does not appear to have guanylate cyclase activity. Thus, the precise roles of the GGDEF domain in the catalysis and structure of Ec DOS remain unclear. In contrast, the EAL domain in Ec DOS appears to contain the catalytic domain, so that this domain retains high phosphodiesterase activity that rapidly converts c-diGMP into linear dinucleotide GMP (l-diGMP) (3, 4). Furthermore, E. coli with a knock-out of the Ec DOS gene display a morphology and growth rate different from those of the wild-type strain, suggesting that the enzyme is important for cell development and/or proliferation (13).

In well known heme-bound gas-sensor proteins, binding of specific gases to the Fe(II) heme (for example, CO for CooA, NO for soluble guanylate cyclase, and O2 for FixL) causes a change in the heme environment that is transduced intramolecularly to the other domain to regulate the function (14). Each of these heme-bound gas-sensor enzymes can recognize only a single physiologically relevant gas. We recently reported, however, that the phosphodiesterase activity of full-length, dithionite-reduced Ec DOS is up-regulated upon binding of either O2 or CO binding to the Fe(II) heme (15). Although the amino acid sequence and overall structure of the heme-containing PAS domains of Ec DOS and FixL are similar, Ec DOS is activated by both O2 and CO, whereas FixL is down-regulated only by O2. Thus, Ec DOS appears to be a novel heme-bound gas-sensor enzyme with the unprecedented ability to recognize more than one type of gas molecule.


Figure 1
View larger version (49K):
[in this window]
[in a new window]

 
FIGURE 1.
Comparison between the crystal structure of Fe(II)-O2 (A, Protein Data Bank code 1VB6) and Fe(II) (B, PDB ID 1V9Z) complex of Ec DOS PAS domains. The atoms of heme (purple), the oxygen molecule bound to the heme (blue), the proximal histidine (white), and residues thought to be involved in ligand sensing (M95, green; R97, yellow) are depicted as stick models. The dashed lines show the hydrogen-bond interactions between the side chain of Arg97 and the oxygen molecule. The figures were prepared using PyMOL (34).

 
To understand why, in contrast to other gas-sensor heme proteins, Ec DOS lacks strict gas selectivity, the roles of the residues around the heme in catalytic activation must be determined. O2 bound to the Fe(II) heme interacts directly with Arg97 on the heme distal side (Fig. 1A) (16). Thus, Arg97 appears to be important for recognizing different gas molecules. Met95 binds directly to the Fe(II) heme as the endogenous axial ligand (Fig. 1B) (17), and the coordination of Met95 to the Fe(II) heme is cleaved by binding of the external axial ligands O2, CO, and NO. Thus, both Arg97 and Met95 may play important roles in the regulation of catalysis by gas binding. To explore the role of these two residues, we generated full-length Ec DOS with mutations at Arg97 and Met95, and examined their catalytic activities and activation by O2, CO, and NO. As in studies of SmFixL (18), in the current experiments, we measured the catalytic activity in the presence of DTT rather than sodium dithionite to more accurately reflect the physiological conditions in vivo.Itwas found that mutation of Arg97 did not significantly affect the catalytic activation by gases, whereas the mutation of Met95 led to high enzyme activity even in the absence of gases as well an inability to be activated by gas binding. Our results imply that Met95 plays a critical role in the activation of c-diGMP hydrolysis upon gas binding by Ec DOS.


    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Materials—All chemical reagents were of the highest grade available and were purchased from Wako Chemicals (Osaka, Japan) and used without further purification. Calf intestine alkaline phosphatase (CIAP) was obtained from Takara Bio (Otsu, Japan), c-diGMP was from BIOLOG (Bremen, Germany), 6-(2-hydroxy-1-methyl-2-nitrosohydrazine)-N-methyl-1-hexanamine (NOC9) was from DOJINDO (Kumamoto, Japan), and BIOMOL GREENTM reagent was from Biomol (Plymouth Meeting, PA). The QuikChangeTM site-directed mutagenesis kit was from Stratagene (La Jolla, CA). Oligonucleotides used for plasmid construction and for site-directed mutagenesis were obtained from Nippon Gene (Sendai, Japan).

Construction of Expression Plasmid and Site-directed Mutagenesis—The cloning of Ec DOS and construction of the expression plasmid pET28a(+) were previously described (19). Mutants were generated as described in the supplementary materials. All constructs were confirmed by DNA sequencing.

Protein Overexpression and Purification—The wild-type and mutant Ec DOS proteins were overexpressed in E. coli BL21(DE3) using the pET28a(+) expression plasmid, which contains an N-terminal His6 tag and a thrombin cleavage site. A single colony was put in 50 ml of Luria-Bertani (LB) medium containing 20 µg/ml kanamycin and 0.5% glucose and then shaken overnight at 200 rpm and 37 °C. The cultured medium was added to 1 liter of terrific broth (TB) medium containing 20 µg/ml kanamycin. Then, the medium was shaken for 4 h at 120 rpm and 37 °C. After the medium was cooled down to 20 °C, {delta}-aminolevulinic acid was added to 0.45 mM and incubated with shaking for another 20 h. The E. coli cells were harvested by centrifugation for 10 min at 5000 x g and 4 °C, and finally stored at -80 °C.

The following protein purification procedures were performed on ice or at 4 °C. E. coli cells frozen at -80 °C were suspended in 50 mM potassium phosphate buffer (pH 7.5) containing 20 mM imidazole, 150 mM NaCl, 5% glycerol, 1 mM phenylmethylsulfonyl fluoride (buffer A), and 0.1 mg/ml lysozyme. The solution was sonicated and then centrifuged at 100,000 x g for 30 min. The supernatants were applied to a nickel-nitrilotriacetic acid-agarose column. The Ec DOS fractions were eluted with a linear gradient of 20–300 mM imidazole in buffer A. The solution containing Ec DOS was dialyzed against 20 mM Tris-HCl (pH 8.0) with 5% glycerol (buffer B), and then thrombin protease (Wako Chemicals, Osaka, Japan) (1 unit/mg of protein) was added to cleave the His tag. Subsequently, the sample solution was applied to a nickel-nitrilotriacetic acid-agarose column, and the His tag-free Ec DOS was eluted in the flow-through fractions using buffer B. The Ec DOS fractions were then applied to DEAE column, and Ec DOS was eluted with a linear gradient of 0–1 M NaCl in buffer B. After the proteins were dialyzed against buffer B, the purified Ec DOS was concentrated with Centriprep (Millipore, Billerica, MA) and Centrisalt I (Sartorius AG, Goettigen, Germany). The purified proteins were >95% homogenous as confirmed by SDS-PAGE. The sample was stored at -20 °C in the presence of 40% glycerol.

Optical Absorption Spectroscopy—All spectral data were obtained using a UV-1600PC (Shimadzu, Kyoto, Japan) spectrophotometer in a glove box that can maintain the oxygen concentration under 100 ppm (Hirasawa, Tokyo, Japan). The heme of Ec DOS proteins was reduced using either 10 mM DTT or small quantities of sodium dithionite in PDE buffer (50 mM Tris-HCl, pH 8.0, 50 mM NaCl, and 5 mM MgCl2) under anaerobic conditions. The Fe(II) heme, Fe(II) heme-O2, and Fe(II) heme-CO complexes were prepared in anoxic (10% H2 and 90% N2 gas), O2-saturated, or CO-saturated buffer, respectively. The gas-saturated buffer solutions were obtained by bubbling the buffer with the appropriate gas for at least 1 h. The Fe(II) heme-NO complexes were prepared by adding of 50 or 100 µM NOC9 to the solution of Fe(II) heme complex.

Phosphodiesterase AssayEc DOS hydrolyzes c-diGMP to l-diGMP as demonstrated by reversed-phase liquid chromatography (supplementary materials Fig. 1S). On the other hand, in our phosphodiesterase assay, we used a colorimetric method, namely, l-diGMP that is converted to a guanylyl (3',5')guanosine by Ec DOS. CIAP reacts with only l-diGMP because CIAP lacks phosphodiesterase activity and thus reacts only with terminal phosphate groups. CIAP therefore converts l-diGMP to GpG (guanylyl (3',5')guanosine) and phosphate. One product, phosphate, was quantified by colorimetrically using BIOMOL GREEN reagent (Biomol). The change in absorbance at 630 nm (supplementary materials Fig. 2S, A) was measured with a Benchmark Microplate ReaderTM (Bio-Rad) and used to determine phosphate concentration by comparison with a standard curve (supplementary materials Fig. 2S, B).

All steps were performed in the globe box. Wild-type and mutant Ec DOS proteins were diluted in PDE buffer. The wild-type and Arg97 mutant enzymes were fully reduced to the Fe(II) form by adding 10 mM DTT. For the Met95 mutants, a trace amount of sodium dithionite was used to completely reduce the heme iron to the Fe(II) complex because DTT cannot reduce the heme iron in the Met95 mutant proteins. Subsequently, excess dithionite was removed by gel filtration on Superdex G-25. After complete reduction the Fe(II) form was confirmed by optical absorption spectroscopy, Fe(II)-CO and Fe(II)-O2 complexes were prepared by diluting the sample in gas-saturated PDE buffer containing 10 mM DTT. The Fe(II)-NO sample was prepared by adding 50 µM or 100 µM NOC9 to the sample of Fe(II) enzyme.

The phosphodiesterase reaction was performed at 25 °C in a mixture with 71.4 mM Tris-HCl (pH 8.0), 71.4 mM NaCl, 7.14 mM MgCl2, 2.14 units/µl of CIAP, 14.3 mM DTT, and 0.29 µM Ec DOS and initiated by the addition of 0.3 volumes of 0.33 mM c-diGMP. After the desired time, the reaction was terminated by the addition of an equal volume of 1 M HCl. The solution was then centrifuged for 5 min at 15,000 x g to remove denatured proteins as precipitates. The supernatant (100 µl) was mixed with 200 µl of BIOMOL GREEN, and the mixture incubated at 25 °C for 30 min. The change in absorbance at 630 nm was measured as described above. The initial rates of the reactions are averages of at least three time course experiments. The experimental errors are shown in the l-diGMP hydrolysis time course data of Fig. 3, and also in Figs. 5S and 6S (supplementary materials). Note that the stick diagrams in Figs. 3B, 4, and supplemental materials Fig. 7S do not have error bars because values were calculated from averaged data points.


Figure 2
View larger version (34K):
[in this window]
[in a new window]

 
FIGURE 2.
Optical absorption spectra of the wild-type (A), R97A (B), R97I (C), and R97E (D) mutant proteins of full-length Ec DOS. Spectra of Fe(II) (solid line), Fe(II)-CO (dotted line), and Fe(II)-NO (dashed line) complexes are presented. Spectra of the Fe(II)-O2 complexes could not be clearly detected due to their rapid autoxidation and/or low affinity for O2.

 

    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Optical Absorption Spectra of the Mutants—We first collected optical absorption spectra for the gas-free and gas-bound Fe(II) heme complexes of the R97A, R97I, and R97E mutants of full-length Ec DOS (Fig. 2). The absorption maxima of the mutant proteins are summarized in Table 1. The optical absorption spectra of these Arg97 mutants in the absence or presence of CO and NO were essentially the same as for the wild-type protein, suggesting that the coordination structure (6-coordinated low-spin form) and the heme environment were not substantially changed by the Arg97 mutations. The spectra of the Fe(II)-O2 complexes for the Arg97 mutants as measured with a conventional absorption spectrometer, however, could not be detected due to rapid autoxidation (>10 s-1) and/or a low affinity for O2 (data not shown). It is likely, therefore, that Arg97 is important for stabilizing the Fe(II)-O2 complex.


View this table:
[in this window]
[in a new window]

 
TABLE 1
Optical absorption spectral maxima (nm) of the Fe(II) complexes for the wild-type, Arg97 mutant, and Met95 mutant proteins in the absence and presence of O2, CO, and NO Coordination structures and spin states of the heme iron are shown in parentheses.

 
Optical absorption spectra of the Met95 mutants of the full-length enzyme for the gas-free and gas-bound Fe(II) heme complexes were essentially the same as those previously reported for the mutants of the isolated heme-bound PAS domain (2022). Note that both the M95A and M95L mutants were 5-coordinate high-spin complexes, whereas the M95H mutant was a 6-coordinate low-spin complex in which His must be an axial ligand.

In the remaining experiments, we reduced the wild-type and Arg97 mutant enzymes to the Fe(II) heme state using DTT, whereas we reduced the Met95 mutant proteins with sodium dithionite. It was, therefore, examined whether there were differences in the optical absorption spectra of the Fe(II) heme complexes when the enzymes were reduced with DTT and sodium dithionite. We found that the spectra of the Fe(II) heme complexes were essentially the same, even if the heme iron was reduced by DTT or sodium dithionite, suggesting that the heme environment of the full-length enzyme is not influenced by the reducing agent.

Phosphodiesterase Activity of the Wild-type Enzyme—Activities of other heme-bound oxygen-sensor enzymes, such as SmFixL, in the presence of DTT are much more sensitive to oxygen and appear to reflect the activity of the native enzyme under hypoxic conditions (18). In the present study, therefore, we used 10 mM DTT to reduce the wild-type enzyme, and we measured the catalytic activity in the glove box to provide anoxic conditions. High pressure liquid chromatography (as shown in supplementary materials Fig. 1S) is used in general to measure phosphodiesterase cleavage of c-diGMP. However, this method is time consuming. In this report, we use colorimetric detection of products in the development of a rapid c-diGMP cleavage assay ("Experimental Procedures" and supplementary materials Fig. 2S).

Fig. 3 shows the time course of l-diGMP generation by Fe(II), Fe(II)-O2, Fe(II)-CO, and Fe(II)-NO complexes of wild-type Ec DOS in the presence of 10 mM DTT. The initial velocities are compared in Fig. 3B and are summarized in Table 2. The binding of O2, CO, or NO to the heme enhanced the activity 6–7-fold. The finding that even NO binding markedly enhanced the catalytic activity was surprising because other heme gas-sensor proteins such as FixL, CooA, and soluble guanylate cyclase strictly distinguish O2, CO, and NO, respectively (14). This emphasizes that Ec DOS is a novel gas-sensor enzyme that has the unprecedented ability to be activated by all three of these gases.


View this table:
[in this window]
[in a new window]

 
TABLE 2
Phosphodiesterase activities (nmol l-diGMP/nmol of Ec DOS) of the Fe(II) complexes of the wild-type, Arg97 mutant, and Met95 mutant enzymes in the absence and presence of O2, CO, and NO Numbers in the parentheses indicate the -fold increase in the activity compared with that of the gas-free wild-type enzyme.

 
Effects of Arg97 Mutations on the Phosphodiesterase Activity—The optical absorption spectra of the Arg97 mutants in the absence or presence of CO and NO were similar to those of the wild-type enzyme (Table 1), suggesting that the heme environments of the mutants and wild-type enzyme are essentially the same. Therefore, we examined the activities of the mutant enzymes in the presence of CO or NO. It was found that CO and NO binding markedly enhanced (6.5–13-fold) the catalytic activity of the three Arg97 mutants, although in the absence of these gases, the activities of the R97A and R97E mutants were lower than that of the wild-type enzyme (Table 2 and supplementary materials Fig. 1S). Because the autoxidation of the O2-bound Arg97 mutant proteins was very rapid (>10 s-1) and/or the affinities of the Fe(II) heme complexes for O2 were low, we could not measure the catalytic activity of the O2-bound Arg97 mutant enzymes.


Figure 3
View larger version (26K):
[in this window]
[in a new window]

 
FIGURE 3.
A, time course of l-diGMP hydrolysis by the Fe(II) ({circ}), Fe(II)-O2 ({blacktriangleup}), Fe(II)-CO (•), and Fe(II)-NO ({blacksquare}) complexes of wild-type Ec DOS. PDE activities were measured in the presence of 10 mM DTT and are given as mean ± S.D. of at least three determinants. B, product generation of the PDE reaction in the absence or presence of gas molecules.

 
Effects of Met95 Mutations on the Phosphodiesterase Activity—Addition of up to 100 mM DTT was not sufficient to fully reduce the Met95 mutants due to the relatively low redox potential of the heme iron in the mutant proteins. This was also observed for the same mutants of the isolated PAS domain (21). Therefore, we used a trace amount of sodium dithionite to completely reduce the heme to the Fe(II) complex. After removing excess sodium dithionite by gel filtration on Sephadex G-25, we measured the catalytic activities of the Met95 mutant proteins in the same buffer containing 10 mM DTT.

Interestingly, the gas-free M95A and M95L mutants showed high activities without gas binding; specifically, the activities of these two mutants were 7–8-fold higher than that of the gas-free wild-type enzyme (Table 1 and supplementary materials Fig. 2S). The activities of the gas-bound bound forms of the mutants were almost as high as the gas-free forms (Table 2). In other words, the catalytic activities of the mutant enzymes were not enhanced by gas binding. In contrast, the activity of the gas-free M95H mutant was 2-fold higher than that of the wild-type enzyme, and the gas molecules enhanced its activity 2–3-fold.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
The PAS fold is characterized by several {alpha}-helices flanking a five-stranded antiparallel beta-sheet scaffold (17, 2933). PAS domains are found in many signaling proteins, where they are used either as signal sensor domains or for protein dimerization (2932). Several PAS domain proteins are known to detect signals through the use of prosthetic groups such as heme or flavin (30, 31). Heme-based PAS sensor proteins detect oxygen, CO, and possibly the cellular redox state (14, 31).

Comparison of the crystal structures of the oxygen-free and oxygen-bound PAS domains of Ec DOS (16, 17) shows that Arg97 undergoes a large change in position when oxygen binding occurs. It might thus be expected that Arg97 should play a prominent role in DOS function. Notably, however, our study clearly shows that this is not the case. The R97A and R97I mutants have activity profiles similar to that of the wild-type enzyme. On the other hand, the M95A and M95L mutants are clearly constitutively "on." In the absence of Met95, the PAS domain presumably assumes a conformation similar to that of the gas-bound protein. Consistent with this idea, the M95H mutant, with a histidine bound to the heme, exhibits properties similar to those of the wild-type enzyme. These data strongly suggest that changes in Met95 coordination structure caused by gas binding (mimicked by mutations at Met95) result in larger conformational changes at the distal side, which subsequently communicate ligand binding information to the catalytic domain.

Effects of Sodium Dithionite and DTT on the Phosphodiesterase Activity of Ec DOS—Although the optical absorption spectra of the Fe(II) complexes for the wild-type and Arg97 mutant proteins were essentially the same when reduced by DTT or sodium dithionite (Fig. 2 and Table 1), the phosphodiesterase activities of the DTT-reduced enzymes were at least 5-fold higher than those of the dithionite-reduced enzymes (Fig. 3 and supplementary materials Fig. 6S). Similar results have been reported for other heme-bound oxygen-sensor enzymes, including the histidine kinase SmFixL (18). The low activity of the dithionite-reduced forms of SmFixL were thought to be due to the formation of an aberrant disulfide bond at Cys301 between Fe(III) homodimers during the preparation of samples under aerobic conditions in the absence of reducing agents. In SmFixL treated with DTT, the disulfide bond was cleaved, leading to more enhancing the enzyme activity.

The wild-type and some mutants of Ec DOS are sometimes purified as the Fe(II)-O2 form (data not shown), suggesting that Ec DOS is present as the Fe(II) form in cells. In general, however, the Fe(III) form along with minor components of Fe(II) and Fe(II)-O2 forms are obtained when Ec DOS is purified under aerobic conditions. Ec DOS contains eight cysteine residues in each monomer. It is possible, therefore, that some cysteine residues in Ec DOS are already oxidized and form disulfide bond(s), leading to lower activity. The following results support the idea that dispensable oxidation caused partial inactivation of Ec DOS. When DTT was removed by G-25 column chromatography, DTT-reduced Ec DOS showed low phosphodiesterase activities for Fe(II), Fe(II)-O2, and Fe(II)-NO complexes, but showed high activity only for the Fe(II)-CO complex (supplementary materials Fig. 5S). O2 and NO molecules are oxidants, and thus, may oxidize cysteine residue(s) or cleave disulfide bonds in Ec DOS, partially inactivating the phosphodiesterase activity.

Role of Arg97 in the Catalysis—The Arg97 mutants autoxidized rapidly (>10 s-1) and/or had low affinities for oxygen. Therefore, Arg97 must be important for stabilizing the O2 molecule bound to the Fe(II) heme by directly binding to the O2 molecule on the heme distal side (16). In contrast, optical absorption spectra suggest that Arg97 is not important for stabilizing the CO and NO molecules bound to the Fe(II) heme. The enhancement of catalytic activity by CO and NO was similar for the Arg97 mutants and the wild-type enzyme. Therefore, Arg97 must not be critical for the enhancement of catalysis by CO and NO.

The structure of the heme-bound sensor PAS domains of SmFixL and Ec DOS are similar. Arg214 in SmFixL, which corresponds to Arg97 in Ec DOS, in the heme distal side directly interacts with the O2 molecule bound to the Fe(II) heme (23). The Fe(II)-O2 complex of SmFixL is inactive, whereas the gas-free Fe(II) complex is active, and Arg214 forms salt bridges with the heme propionate in the gas-free Fe(II) complex (23). Therefore, the O2 molecule has opposite roles in the catalysis of SmFixL and Ec DOS. For SmFixL, the distal Arg214 is thought to be essential for the regulation of kinase activity by ligand binding, O2 binding, and, therefore, reduced autoxidation of the Fe(II)-O2 complex (24, 25). The optical absorption spectra suggest that Arg97 in Ec DOS stabilizes the Fe(II)-O2 form and that the interaction of Arg97 with the gas ligand may not be important for the activation of catalysis by ligand binding (Table 2 and Fig. 4).


Figure 4
View larger version (51K):
[in this window]
[in a new window]

 
FIGURE 4.
Comparison of the catalytic activities of the Fe(II) (white), Fe(II)-O2 (hatched), Fe(II)-CO (gray), and Fe(II)-NO (black) complexes of the Arg97 (A) and Met95 (B) mutant enzymes.

 
It has been suggested that specific steric and/or electrostatic effects destabilize the Fe(II)-O2 complex (20, 28). In general, an increase in accessibility of the distal pocket to either solvent water molecules or to other polar residues, or protonation of the O2 molecule bound to the Fe(II) heme, accelerate autoxidation of the Fe(II)-O2 complex. The increase in autoxidation rate seen in the Arg97 mutants suggests that Arg97 mutations lead to increases in interaction of polar molecules with the Fe(II)-O2 complex. These findings contrast with data from tests with M95A and M95L mutants, where the mutations significantly decreased the autoxidation rate (20). Isolation of the PAS domain also decreased the autoxidation rate (20).

Role of Met95 in the Catalysis—Met95 is the sixth axial ligand in the gas-free Fe(II) complex. Met95 must move away from the heme iron upon binding of exogenous ligand to Fe(II) heme (Fig. 1). Previous studies indicate that mutations at Met95 in the isolated heme-bound PAS domain of Ec DOS substantially increase the affinities of the heme iron for O2, CO, and CN- and that the heme redox potential is also markedly changed by Met95 mutations (20, 21, 26). The role of Met95 in catalytic regulation, however, has been unclear.

In the present study, we found that the activities of the gas-free M95A and M95L mutant enzymes were already similar to those of the gas-bound wild-type enzymes (Table 2). Therefore, it appears that Met95 is critical for regulating the catalytic activity of Ec DOS. In the gas-free form, the M95A and M95L mutants are 5-coordinate high-spin complexes, in contrast to the wild-type and Arg97 mutant enzymes, which are 6-coordinate low-spin complexes. In the wild-type and Arg97 mutant enzymes, cleavage of the Met95 coordination to the Fe(II) heme occurs upon gas binding. On the other hand, in the M95A and M95L mutants, as in the gas-bound wild-type and Arg97 mutant proteins, there is no bond between the residue at position 95 and the Fe(II) heme iron. Certain structural change(s) near the main or side chain of Met95 on the heme distal side must occur upon binding of the gas ligand. There may be a similar structure(s) in the Fe(II) complex of the M95A and M95L mutants even in the absence of the gas molecules, which lead to the high activities of the gas-free Fe(II) heme enzymes (Table 2 and Fig. 4).

It is interesting that the M95H mutant is the 6-coordinate low-spin complex, probably as a result of His95 coordination to the Fe(II) heme iron. The catalytic activity of the gas-free form of this mutant was lower than those of other Met95 mutants that are 5-coordiante high-spin complexes. On the other hand, gas binding by this mutant enhanced its activity 2–3-fold, which is higher than that observed for other Met95 mutant proteins. Perhaps a certain conformational change(s) caused by the M95H mutation influences the activity of the gas-free M95H mutant enzyme, leading to activities intermediate between the wild-type/Arg97 and M95A/M95L mutants. Collectively, the results suggest that Met95 coordination to the Fe(II) heme is a key factor in the down-regulation of catalysis so that its removal by gas binding or the M95A or M95L mutations enhances the catalytic activity.

Comparison with Catalysis of Ec DOS toward cAMP—Recent studies of the cAMP phosphodiesterase activity of Ec DOS indicate that cAMP is hydrolyzed by the Fe(II) heme form but not the Fe(III) form of Ec DOS (19). Furthermore, binding of CO or NO to the Fe(II) heme complex eliminates the ability to hydrolyze cAMP. X-ray crystal structural studies of the isolated heme-bound PAS domain of Ec DOS indicate that profound structural changes of the heme-bound PAS domain occur upon changes in the redox state (17). Such redox-dependent structural changes appear to reflect the redox-dependent regulation in the cAMP phosphodiesterase activity of Ec DOS. Furthermore, knocking down the Ec DOS gene in E. coli causes changes in cell growth rate, cell morphology, and intracellular cAMP concentration, suggesting that Ec DOS plays an important role in modulating the cellular effects of cAMP (13).

In the present study, we showed that, in addition to cAMP, Ec DOS hydrolyzes c-diGMP. The mechanism by which c-diGMP hydrolysis is regulated differs from that regulating cAMP hydrolysis. Namely, the c-diGMP phosphodiesterase activity of Ec DOS is substantially up-regulated by the binding of gas molecules. Furthermore, it is important to note that, unlike other heme-bound gas-sensor enzymes and proteins (14), Ec DOS does not discriminate between O2, CO, and NO. Further studies are needed to understand the mechanisms of gas sensing and intramolecular signal transduction by this novel enzyme. It will also be interesting to investigate the intracellular cross-talk between the two substrates of Ec DOS, cAMP and c-diGMP (27).


    FOOTNOTES
 
* This work was supported in part by the Grand-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental data and Figs. S1–S7. Back

1 To whom correspondence should be addressed: 2-1-1 Katahira, Aoba-ku, Sendai 980-8577, Japan. Tel.: 81-22-217-5604/5605/5606; Fax: 81-22-217-5604/5605/5390; E-mail: shimizu{at}tagen.tohoku.ac.jp.

2 The abbreviations used are: c-diGMP, cyclic dinucleotide-GMP; GGDEF subdomain, a subdomain that characteristically expresses diguanylate cyclase activity, used to synthesize cyclic diGMP; EAL subdomain, a subdomain that characteristically expresses phosphodiesterase activity and hydrolytically cleaves cyclic diGMP; l-diGMP, linear dinucleotide GMP; Ec DOS, Escherichia coli direct oxygen sensor or heme-regulated phosphodiesterase from E. coli; PAS, Per (Drosophila period clock protein)-Arnt (vertebrate aryl hydrocarbon receptor nuclear translocator)-Sim (Drosophila single-minded protein); SmFixL, an oxygen sensor heme protein from Sinorhizobium meliloti; CooA, CO-sensing heme-bound transcriptional regulator from Rhodospirillum rubrum; DTT, dithiothreitol; CIAP, calf intestine alkaline phosphatase; NOC9, 6-(2-hydroxy-1-methyl-2-nitrosohydrazine)-N-methyl-1-hexanamine; PDE, phosphodiesterase. Back



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Römling, U., and Amikam, D. (2006) Curr. Opin. Microbiol. 9, 218-228[CrossRef][Medline] [Order article via Infotrieve]
  2. Galperin, M. Y. (2004) Environ. Microbiol. 6, 552-567[CrossRef][Medline] [Order article via Infotrieve]
  3. Méndez-Ortiz, M. M., Hyodo, M., Hayakawa, Y., and Membrillo-Hernández, J. (2006) J. Biol. Chem. 281, 8090-8099[Abstract/Free Full Text]
  4. Schmidt, A. J., Ryjenkov, D. A., and Gomelsky, M. (2005) J. Bacteriol. 187, 4774-4781[Abstract/Free Full Text]
  5. Ryjenkov, D. A., Simm, R., Römling, U., and Gomelsky, M. (2006) J. Biol. Chem. 281, 30310-30314[Abstract/Free Full Text]
  6. Hoffman, L. R., D'Argenio, D. A., MacCoss, M. J., Zhang, Z., Jones, R. A., and Miller, S. I. (2005) Nature 436, 1171-1175[CrossRef][Medline] [Order article via Infotrieve]
  7. Christen, M., Christen, B., Folcher, M., Schauerte, A., and Jenal, U. (2005) J. Biol. Chem. 280, 30829-30837[Abstract/Free Full Text]
  8. Tamayo, R., Tischler, A. D., and Camilli, A. (2005) J. Biol. Chem. 280, 33324-33330[Abstract/Free Full Text]
  9. Kulesekara, H., Lee, V., Brencic, A., Liberati, N., Urbach, J., Miyata, S., Lee, D. G., Neely, A. N., Hyodo, M., Hayakawa, Y., Ausubel, F. M., and Lory, S. (2006) Proc. Natl. Acad. Sci. U. S. A. 103, 28392844
  10. Karaolis, D. K. R., Chen, K., Lipsky, M., Elnabawi, A., Catalano, J., Hyodo, M., Hayakawa, Y., and Raufman, J.-P. (2005) Biochem. Biophys. Res. Commun. 329, 40-45[CrossRef][Medline] [Order article via Infotrieve]
  11. Delgado-Nixon, V. M., Gonzalez, G., and Gilles-Gonzalez, M. A. (2000) Biochemistry 39, 2685-2691[CrossRef][Medline] [Order article via Infotrieve]
  12. Chang, A. L., Tuckerman, J. R., Gonzalez, G., Mayer, R., Weinhouse, H., Volman, G., Amikam, D., Benziman, M., and Gilles-Gonzalez, M. A. (2001) Biochemistry 40, 3420-3426[CrossRef][Medline] [Order article via Infotrieve]
  13. Yoshimura-Suzuki, T., Sagami, I., Yokota, N., Kurokawa, H., and Shimizu, T. (2005) J. Bacteriol. 187, 6678-6682[Abstract/Free Full Text]
  14. Gilles-Gonzalez, M. A., and Gonzalez, G. (2005) J. Inorg. Biochem. 99, 1-22[CrossRef][Medline] [Order article via Infotrieve]
  15. Takahashi, H., and Shimizu, T. (2006) Chem. Lett. 35, 970-971[CrossRef]
  16. Park, H., Suquet, C., Satterlee, J. D., and Kang, C.-H. (2004) Biochemistry 43, 2738-2746[CrossRef][Medline] [Order article via Infotrieve]
  17. Kurokawa, H., Lee, D. S., Watanabe, M., Sagami, I., Mikami, B., Raman, C. S., and Shimizu, T. (2004) J. Biol. Chem. 279, 20186-20193[Abstract/Free Full Text]
  18. Akimoto, S., Tanaka, A., Nakamura, K., Shiro, Y., and Nakamura, H. (2003) Biochem. Biophys. Res. Commun. 304, 136-142[CrossRef][Medline] [Order article via Infotrieve]
  19. Sasakura, Y., Hirata, S., Sugiyama, S., Suzuki, S., Taguchi, S., Watanabe, M., Matsui, T., Sagami, I., and Shimizu, T. (2002) J. Biol. Chem. 277, 23821-23827[Abstract/Free Full Text]
  20. Taguchi, S., Matsui, T., Igarashi, J., Sasakura, Y., Araki, Y., Ito, O., Sugiyama, S., Sagami, I., and Shimizu, T. (2004) J. Biol. Chem. 279, 3340-3347[Abstract/Free Full Text]
  21. Hirata, S., Matsui, T., Sasakura, Y., Sugiyama, S., Yoshimura, T., Sagami, I., and Shimizu, T. (2003) Eur. J. Biochem. 270, 4771-4779[Medline] [Order article via Infotrieve]
  22. Sato, A., Sasakura, Y., Sugiyama, S., Sagami, I., Shimizu, T., Mizutani, Y., and Kitagawa, T. (2002) J. Biol. Chem. 277, 32650-32658[Abstract/Free Full Text]
  23. Gong, W., Hao, B., and Chan, M. K. (2000) Biochemistry 39, 3955-3962[CrossRef][Medline] [Order article via Infotrieve]
  24. Tanaka, A., Nakamura, H., Shiro, Y., and Fujii, H. (2006) Biochemistry 45, 2515-2523[CrossRef][Medline] [Order article via Infotrieve]
  25. Dunham, C. M., Dioum, E. M., Tuckerman, J. R., Gonzalez, G., Scott, W. G., and Gilles-Gonzalez, M. A. (2003) Biochemistry 42, 7701-7708[CrossRef][Medline] [Order article via Infotrieve]
  26. Watanabe, M., Matsui, T., Sasakura, Y., Sagami, I., and Shimizu, T. (2002) Biochem. Biophys. Res. Commun. 299, 169-172[CrossRef][Medline] [Order article via Infotrieve]
  27. Sasakura, Y., Yoshimura-Suzuki, T., Kurokawa, H., and Shimizu, T. (2006) Acc. Chem. Res. 39, 37-43[CrossRef][Medline] [Order article via Infotrieve]
  28. Springer, B. A., Sligar, S. G., Olson, J. S., and Phillips, G. N., Jr. (1994) Chem. Rev. 94, 699-714[CrossRef]
  29. El-Mashtoly, S. F., Takahashi, H., Shimizu, T., and Kitagawa, T. (2007) J. Am. Chem. Soc. 129, 3556-3563[CrossRef][Medline] [Order article via Infotrieve]
  30. Crosson, S., and Moffat, K. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 2995-3000[Abstract/Free Full Text]
  31. Jain, R., and Chan, M. K. (2003) J. Biol. Inorg. Chem. 8, 1-11[CrossRef][Medline] [Order article via Infotrieve]
  32. Yang, J., Zhang, L., Erbel, P. J. A., Gardner, K. H., Ding, K., Garcia, J. A., and Bruick, R. K. (2005) J. Biol. Chem. 280, 36047-36054[Abstract/Free Full Text]
  33. Vreede, J., van der Horst, M. A., Hellinger, K. J., Crielaard, W., and van Aalten, D. M. F. (2003) J. Biol. Chem. 278, 18434-18439[Abstract/Free Full Text]
  34. DeLano, W. L. (2002) The PyMOL Molecular Graphics System, DeLano Scientific, San Carlos, CA



This article has been cited by other articles:


Home page
J. Bacteriol.Home page
R. L. Kerby, H. Youn, and G. P. Roberts
RcoM: A New Single-Component Transcriptional Regulator of CO Metabolism in Bacteria
J. Bacteriol., May 1, 2008; 190(9): 3336 - 3343.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. F. El-Mashtoly, Y. Gu, H. Yoshimura, S. Yoshioka, S. Aono, and T. Kitagawa
Protein Conformation Changes of HemAT-Bs upon Ligand Binding Probed by Ultraviolet Resonance Raman Spectroscopy
J. Biol. Chem., March 14, 2008; 283(11): 6942 - 6949.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Yamashita, L. Bouzhir-Sima, J.-C. Lambry, U. Liebl, and M. H. Vos
Ligand Dynamics and Early Signaling Events in the Heme Domain of the Sensor Protein Dos from Escherichia coli
J. Biol. Chem., January 25, 2008; 283(4): 2344 - 2352.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/29/21301    most recent
M701920200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanaka, A.
Right arrow Articles by Shimizu, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanaka, A.
Right arrow Articles by Shimizu, T.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.